Market Currents
Five major drug companies are still in the hunt to acquire Amylin (AMLN) as the auction enters...
-
Tuesday, June 26, 2012, 12:42 PM ETFive major drug companies are still in the hunt to acquire Amylin (AMLN) as the auction enters its final stage, Reuters reports, with final bids expected to start coming in at the end of the week. The runners and riders are Novartis (NVS), Sanofi (SNY), Bristol Myers (BMY), AstraZenica (AZN) and Merck (MRK). (See also)
Other date
Latest Articles
